Home > Financial Ratios > AARTI DRUGS

AARTI DRUGS
Core EBITDA Growth

    Back to All Ratios
AARTI DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -5.634.24-9.38-22.7066.63

What is the latest Core EBITDA Growth ratio of AARTI DRUGS ?

The latest Core EBITDA Growth ratio of AARTI DRUGS is -5.63 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-5.63
Mar20244.24
Mar2023-9.38
Mar2022-22.70
Mar202166.63

How is Core EBITDA Growth of AARTI DRUGS Trending?

Years Core EBITDA Growth % Change
Mar2025 -5.63
Negative
Mar2024 4.24
Positive
Mar2023 -9.38
Negative
Mar2022 -22.7
Negative
Mar2021 66.63 -

Other Financial Ratios of AARTI DRUGS


Compare Core EBITDA Growth ratio of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹4,123.1 Cr -4.7% -13.9% -2.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,211.0 Cr 1.6% 6% -2% Stock Analytics
DIVIS LABORATORIES ₹171,898.0 Cr -0.7% -1.9% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,377.0 Cr -0.8% 7.4% 21.2% Stock Analytics
CIPLA ₹122,349.0 Cr -0.4% -3.4% 0.8% Stock Analytics
DR REDDYS LABORATORIES ₹103,789.0 Cr 1.2% 0.3% -1.5% Stock Analytics


AARTI DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

-4.7%

-13.9%

-2.7%

SENSEX

1%

2.5%

6.5%


You may also like the below Video Courses